Asia Spotlight: Understanding Regs Key As CFDA Toughens GMP Enforcement
The China FDA is substantially beefing up inspections of foreign drug manufacturing sites, showing assertiveness and confidence towards China's own GMP standards after a massive domestic campaign to root out quality violators. Staying out of trouble in the world's second largest pharma market will require keeping on top of local regulatory update.
You may also be interested in...
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
China releases technical requirements for foreign drug makers to register their chemical drugs in the country, and issues patent linkage details, which a legal expert says needs to be closely examined.